These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 17222253)
1. Heterogeneous expression of alpha-methylacyl-CoA racemase in prostatic cancer correlates with Gleason score. Murphy AJ; Hughes CA; Lannigan G; Sheils O; O'Leary J; Loftus B Histopathology; 2007 Jan; 50(2):243-51. PubMed ID: 17222253 [TBL] [Abstract][Full Text] [Related]
2. Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone. Leav I; McNeal JE; Ho SM; Jiang Z Hum Pathol; 2003 Mar; 34(3):228-33. PubMed ID: 12673556 [TBL] [Abstract][Full Text] [Related]
3. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer. Luo J; Zha S; Gage WR; Dunn TA; Hicks JL; Bennett CJ; Ewing CM; Platz EA; Ferdinandusse S; Wanders RJ; Trent JM; Isaacs WB; De Marzo AM Cancer Res; 2002 Apr; 62(8):2220-6. PubMed ID: 11956072 [TBL] [Abstract][Full Text] [Related]
4. Kinetic fluorescence reverse transcriptase-polymerase chain reaction for alpha-methylacyl CoA racemase distinguishes prostate cancer from benign lesions. Schostak M; Miller K; Krause H; Schrader M; Kempkensteffen C; Kollermann J Cancer Detect Prev; 2006; 30(5):449-54. PubMed ID: 17067752 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate. Herawi M; Epstein JI Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076 [TBL] [Abstract][Full Text] [Related]
6. Alpha-methylacyl-CoA racemase (AMACR) expression in normal prostatic glands and high-grade prostatic intraepithelial neoplasia (HGPIN): association with diagnosis of prostate cancer. Ananthanarayanan V; Deaton RJ; Yang XJ; Pins MR; Gann PH Prostate; 2005 Jun; 63(4):341-6. PubMed ID: 15602744 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of alpha-methylacyl-coA racemase among men with high grade prostatic intraepithelial neoplasia in prostate biopsies. Stewart J; Fleshner N; Cole H; Toi A; Sweet J J Urol; 2008 May; 179(5):1751-5; discussion 1755. PubMed ID: 18343427 [TBL] [Abstract][Full Text] [Related]
8. [Detection of AMACR (P504S), P63 and 34betaE12 cocktail in the early diagnosis of prostate cancer]. Yu T; Zhu SX; Zheng S; Chen SP Zhonghua Nan Ke Xue; 2007 Mar; 13(3):222-5. PubMed ID: 17393784 [TBL] [Abstract][Full Text] [Related]
9. Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker. Jiang Z; Wu CL; Woda BA; Iczkowski KA; Chu PG; Tretiakova MS; Young RH; Weiss LM; Blute RD; Brendler CB; Krausz T; Xu JC; Rock KL; Amin MB; Yang XJ Histopathology; 2004 Sep; 45(3):218-25. PubMed ID: 15330799 [TBL] [Abstract][Full Text] [Related]
10. Comparison of monoclonal antibody (P504S) and polyclonal antibody to alpha methylacyl-CoA racemase (AMACR) in the work-up of prostate cancer. Kunju LP; Chinnaiyan AM; Shah RB Histopathology; 2005 Dec; 47(6):587-96. PubMed ID: 16324196 [TBL] [Abstract][Full Text] [Related]
11. Detection of prostate cancer by alpha-methylacyl CoA racemase (P504S) in needle biopsy specimens previously reported as negative for malignancy. Carswell BM; Woda BA; Wang X; Li C; Dresser K; Jiang Z Histopathology; 2006 May; 48(6):668-73. PubMed ID: 16681682 [TBL] [Abstract][Full Text] [Related]
13. Alpha-methylacyl-CoA racemase (AMACR) in fine-needle aspiration specimens of prostate lesions. Kaić G; Tomasović-Loncarić C Diagn Cytopathol; 2009 Nov; 37(11):803-8. PubMed ID: 19459159 [TBL] [Abstract][Full Text] [Related]
14. [Detection of P504S (alpha-methylacyl-CoA racemase) in prostatic adenocarcinomas]. Xiao Y; Chen J; Luo YF; Cao JL; Ling Q; Jin F Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(16):1362-6. PubMed ID: 15387946 [TBL] [Abstract][Full Text] [Related]
15. Decreased alpha-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death. Rubin MA; Bismar TA; Andrén O; Mucci L; Kim R; Shen R; Ghosh D; Wei JT; Chinnaiyan AM; Adami HO; Kantoff PW; Johansson JE Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1424-32. PubMed ID: 15941951 [TBL] [Abstract][Full Text] [Related]
16. Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance. Lin A; Weiser MR; Klimstra DS; Paty PB; Tang LH; Al-Ahmadie H; Hoo Park S; Guillem JG; Temple L; Wong WD; Gerald WL; Shia J Hum Pathol; 2007 Jun; 38(6):850-6. PubMed ID: 17442371 [TBL] [Abstract][Full Text] [Related]
17. Comparison of annexin II, p63 and alpha-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study. Stewart J; Fleshner N; Cole H; Sweet J J Clin Pathol; 2007 Jul; 60(7):773-80. PubMed ID: 16916997 [TBL] [Abstract][Full Text] [Related]
18. Human telomerase and alpha-methylacyl-coenzyme A racemase in prostatic carcinoma. A comparative immunohistochemical study. Puebla-Mora AG; Heras A; Cano-Valdez AM; Domínguez-Malagón H Ann Diagn Pathol; 2006 Aug; 10(4):205-8. PubMed ID: 16844561 [TBL] [Abstract][Full Text] [Related]
19. Altered expression of alpha-methylacyl-coenzyme A racemase in prostatic adenocarcinoma following hormone therapy. Suzue K; Montag AG; Tretiakova M; Yang XJ; Sahoo S Am J Clin Pathol; 2005 Apr; 123(4):553-61. PubMed ID: 15743746 [TBL] [Abstract][Full Text] [Related]
20. The prostate-specific G-protein coupled receptors PSGR and PSGR2 are prostate cancer biomarkers that are complementary to alpha-methylacyl-CoA racemase. Wang J; Weng J; Cai Y; Penland R; Liu M; Ittmann M Prostate; 2006 Jun; 66(8):847-57. PubMed ID: 16491480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]